Developing catalytic reactions using nonprecious-metal to achieve various synthetic transformations remains a valuable pursuit to the scientific community. As part of a continuing review series that is published within the precompetitive chemistry alliance between AbbVie, Boehringer Ingelheim and Pfizer, this review article underscores the wide-ranging synthetic uses of Cu-, Co-, Fe-, and Ni-catalysis. The significant uptick in NPMC-related publications signifies the escalating curiosity among researchers to investigate and advance the catalytic capabilities of these metals.
No takes yet. Share an insight, caveat, or question.
Sripada et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: